Stability of parenteral solutions of cefazolin sodium.
D000818:Animals; D001412:Bacillus subtilis / Q000187:drug effects; D002511:Cephalosporins / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology* / Q000633:toxicity; D002855:Chromatography, Thin Layer; D004355:Drug Stability; D004356:Drug Storage; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D007928:Lethal Dose 50; D051379:Mice; D008826:Microbial Sensitivity Tests; D011048:Polarography; D013056:Spectrophotometry, Ultraviolet; D013440:Sulfides / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology / Q000633:toxicity; D013696:Temperature; D013777:Tetrazoles / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology / Q000633:toxicity; D013830:Thiadiazoles / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology / Q000633:toxicity; D013997:Time Factors
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles